Lansoprazole Capsule, Delayed Release
Product Images NDC 50090-7651

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-7651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

This information provides the mean severity of day heartburn based on study day for evaluable patients. The severity is categorized as mild, moderate, severe, or none, with corresponding numbers (1, 2, 3, 0). The data shows the comparison between patients taking placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD over the treatment duration.*

FDA Label Image

Figure-2.jpg (Figure 2)

This data compares the mean severity of night heartburn for evaluable patients by study day. The severity is rated on a scale of 0 to 3, where 3 is severe, 2 is moderate, 1 is mild, and 0 is none. Different treatments such as placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD were evaluated over a period of days from the start of treatment.*

FDA Label Image

Formula-structure.jpg (Image 01)

FDA Label Image

Label Image (Lbl500907651)

This is information about a delayed-release medication containing 30 mg of Esomeprazole. The packaging consists of 90 capsules, and it should be stored at temperatures between 68-77 degrees Fahrenheit. The product appears to be named "1mc, zotpe."*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.